Friday, Aug 23, 2024 · SEC filings
What the smart money revealed on Aug 23
394 insider filings came in. We hid 67 planned (10b5-1) sellers and 146 people whose filings were routine, like grants and tax withholding.
Coupang (CPNG) Director Neil Mehta bought $6.88M
300,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Zivo Bioscience (ZIVO) Director Christopher Maggiore bought $261K
31,336 shares on the open market. Not a grant or an option exercise.
VF (VFC) Director Richard Carucci bought $250K
15,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.
StepStone Private Infrastructure Fund (STRUX) Director Thomas Sittema bought $250K
20,661 shares on the open market. Not a grant or an option exercise.
Allstate (ALL) Chairman Thomas Wilson sold $32M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day.
Procter & Gamble (PG) CEO - Baby Ma. Francisco sold $16.3M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 13,721 shares directly.
M&T Bank (MTB) Director Kirk Walters sold $377K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 33 more real buys
Show 112 more real sales
13F season
Holdings as of Jun 30, 2024 were due Aug 14
54 funds have filed. 50 filed for the quarter before.
Biggest real insider buys, Aug 17–23
Open-market buys by officers and directors, filed in the 7 days up to Aug 23.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.